Biotech · Public company · Grapevine, TX, US
Alpha Cognition Inc.
Ticker ACOG · SEC CIK 0001655923
Track this companyFree. Adds Alpha Cognition Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- Zunveyl®Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)PHASE4 · RECRUITING · started May 20, 2026ClinicalTrials.gov NCT07633470 · fetched Nov 12, 2026
SEC filings12
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 23, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K/A · FORM 8-K/ASEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 20, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Apr 14, 2026 · fetched Nov 12, 2026
- 10-K · ANNUAL REPORTSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Mar 27, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Mar 26, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Feb 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 15, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed Nov 13, 2025 · fetched Nov 12, 2026